| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 558087000 |
Processes
| 73 |
| 558073000 |
The phosphorus is in a ring
| 28 |
| 558166000 |
Nitrogen attached indirectly to the phosphorus by acyclic nonionic bonding
| 9 |
| 558177000 |
Chalcogen attached indirectly to the phosphorus by acyclic nonionic bonding
| 8 |
| 558155000 |
Plural phosphori attached directly or indirectly to each other by nonionic bonding | 3 |
| 20130109878 | 4-Alkylresorcinol Derivative And External Preparation For Skin Containing The Same | 05-02-2013 |
| 20080319216 | Salt of a Sulfur-Containing, Phosphorus-Containing Compound, And Methods Thereof - There is disclosed a salt of a sulfur-containing, phosphorus-containing compound. There is also disclosed a method of making the salt. | 12-25-2008 |
| 20130066098 | Remote Assembly of Targeted Nanoparticles using H-Phosphate ENE/-YNE Hydrophosphonylation Reactions - The present invention provides phosphonate compounds and methods of preparing the phosphonate compounds so as to allow, for example, increased capability to modify nanoparticles for targeted drug delivery applications. | 03-14-2013 |
| 558194000 |
Chalcogen attached indirectly to the phosphorus by nonionic bonding | 3 |
| 20130338390 | SYNTHESIS OF RESVERATROL-BASED COMPOUNDS - A compound having the structure: | 12-19-2013 |
| 20130030209 | PHOSPHINATE RUTHENIUM COMPLEXES - Provided herein are ruthenium complexes of Formula I, and processes of preparation thereof. Also provided are methods of their use as a metathesis catalyst. | 01-31-2013 |
| 20150080597 | ARYLFLUOROPHOSPHATE INHIBITORS OF INTESTINAL APICAL MEMBRANE SODIUM/PHOSPHATE CO-TRANSPORT - The present invention is directed to fluorophosphates, and pharmaceutical compositions thereof, which are inhibitors of intestinal apical sodium/phosphate co-transport and are useful in the treatment of hyperphosphatemia, in reducing blood phosphate levels, and in treating hypertension. | 03-19-2015 |
| 558203000 |
Halogen attached indirectly to the phosphorus by acyclic nonionic bonding | 2 |
| 20080227997 | Preparation of phosphorus-containing propoxylation products by using aluminium trichloride - The invention describes a process for preparing propoxylated, phosphorus-containing compounds using aluminium chloride catalyst. | 09-18-2008 |
| 20130274499 | Synthesis of 2,4-Pyrimidinediamines - Disclosed herein are methods for synthesizing 2,4-pyrimidinediamines as well as intermediates used therein. | 10-17-2013 |
| 558207000 |
Divalent chalcogen double bonded directly to the phosphorus | 2 |
| 20130178642 | METHOD OF PREPARING BIPHENYL-4-YL DIPHENYL PHOSPHATE COMPOSITION - Provided is a method of preparing a biphenyl-4-yl diphenyl phosphate composition for use as a flame retardant or a plasticizer for resin, including mixing phosphoryl chloride (POCl | 07-11-2013 |
| 20160107986 | IMPROVED METHOD FOR PRODUCING SPECIFIC OXIMES AND OXIMETHERS - Method for preparing certain oximes and oxime O-methyl ethers by reacting poorly water-soluble carbonyl compounds with salts of hydroxylamine or hydroxylamine O-methyl ether or the free base of hydroxylamine in the presence of certain phosphoric esters or salts thereof of the formula (I) | 04-21-2016 |
| 558072000 |
Boron containing | 1 |
| 20120010424 | LPA Receptor Agonists and Antagonists - Disclosed are compounds according to formula (I) as well as pharmaceutical compositions which include those compounds. Also disclosed are methods of using such compounds, which have activity as agonists or as antagonists of LPA receptors; such methods including treating cancer, producing radioprotection and/or radiomitigation, enhancing cell proliferation, treating a wound, treating apoptosis or preserving or restoring function in a cell, tissue, or organ, culturing cells, preserving organ or tissue function, and treating a dermato logical condition. | 01-12-2012 |
| 558190000 |
Nitrogen attached indirectly to the phosphorus by nonionic bonding | 1 |
| 20110251418 | CASR AGONISTS - By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof. | 10-13-2011 |
| 558152000 |
Plural phosphori bonded to the same chalcogen (e.g., pyrophosphate esters, etc.) | 1 |
| 20130190524 | CYCLITOLS AND THEIR DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS - The present invention is directed to polyphosphorylated and pyrophosphate derivatives of cyclitols. More particularly, the invention relates to polyphosphorylated and pyrophosphate derivatives of inositols. The invention also relates to compositions of the polyphosphorylated and pyrophosphate derivatives of inositol and other similar, more lipophilic derivatives, and their use as allosteric effectors, cell-signaling molecule analogs, and therapeutic agents. | 07-25-2013 |
